Tag: Cordis

TOP 10

Interventional News’ top 10 most popular stories of October 2022

Interventional News’ most popular content last month featured a report on the need for greater interventional radiology (IR) service coverage in rural areas of...

Cordis announces acquisition of MedAlliance

Cordis today announced its acquisition, subject to customary closing conditions including regulatory approvals, of MedAlliance. A press release notes that the agreement includes an...
Cordis

Cordis announces start of enrolment in RADIANCY clinical study in Europe

Cordis has announced the start of the RADIANCY premarket clinical study in Europe. A press release details that RADIANCY is a prospective, multicentre, single-arm...
Cordis

Cordis announces successful first-in-human use of the Radianz radial peripheral system

Cordis recently announced the first-in-human use of the Radianz radial peripheral system by Jihad Mustapha at Advanced Cardiac & Vascular Centers (ACV) Grand Rapids,...
Cordis

Cordis makes strategic investment in E2, a developer of next-generation thrombectomy...

Cordis has announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the venous thromboembolism (VTE) market...

S.M.A.R.T. Radianz vascular stent system approved for transradial use in the...

Cordis recently announced that the US Food and Drug Administration (FDA) has approved the S.M.A.R.T. Radianz vascular stent system, a self-expanding stent purposefully engineered...

Jeremy Durack and John Simpson to join Cordis-X innovation accelerator

Ajax Health has announced the appointments of two cardiovascular professionals to Cordis-X, an independent accelerator created to drive innovation and growth to Cordis.  "Since the...

Cordis names George Adams as chief medical officer

Cordis has announced George Adams as chief medical officer.  "We are delighted to have Dr Adams join our team as we continue to build the...

Cardinal Health signs definitive agreement to sell its Cordis business to...

Cardinal Health recently announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately US$1...
Lorenzo Patrone shares with Blearning at CIRSE, the benefits of using the OUTBACK™ Elite Re-entry Catheter

OUTBACK™ Elite Re-entry catheter highly effective at saving limbs in extreme...

 Lorenzo Patrone (London, UK) shares with Blearning at CIRSE 2019 (7–11 September, Barcelona, Spain) the benefits of using the OUTBACK™ Elite Re-entry Catheter (Cordis,...